Intranasal immunization with cytotoxic T-lymphocyte epitope peptide and mucosal adjuvant cholera toxin: selective augmentation of peptide-presenting dendritic cells in nasal mucosa-associated lymphoid tissue

Intranasal immunization with cytotoxic T-lymphocyte epitope peptide and mucosal adjuvant cholera toxin: selective augmentation of peptide-presenting dendritic cells in nasal mucosa-associated lymphoid tissue

Item
http://www.wikidata.org/entity/Q33769366
Towards a rational design of an asymptomatic clinical herpes vaccine: the old, the new, and the unknownOrchestration of angiogenesis by immune cellsIntranasal immunization with SAG1 and nontoxic mutant heat-labile enterotoxins protects mice against Toxoplasma gondii.Trachea, lung, and tracheobronchial lymph nodes are the major sites where antigen-presenting cells are detected after nasal vaccination of mice with human papillomavirus type 16 virus-like particles.Bordetella bronchiseptica persists in the nasal cavities of mice and triggers early delivery of dendritic cells in the lymph nodes draining the lower and upper respiratory tractCC chemokine receptor 7 expression by effector/memory CD4+ T cells depends on antigen specificity and tissue localization during influenza A virus infection.AB toxins: a paradigm switch from deadly to desirableNod2-mediated recognition of the microbiota is critical for mucosal adjuvant activity of cholera toxinRole of lymphotoxin and homeostatic chemokines in the development and function of local lymphoid tissues in the respiratory tract.Toxins-useful biochemical tools for leukocyte research.Increased antigen specific T cell numbers in the absence of altered migration or division rates as a result of mucosal cholera toxin administration.Cholera toxin and heat-labile enterotoxin activate human monocyte-derived dendritic cells and dominantly inhibit cytokine production through a cyclic AMP-dependent pathway.An enzymatically active a domain is required for cholera-like enterotoxins to induce a long-lived blockade on the induction of oral tolerance: new method for screening mucosal adjuvants.In vivo activation of naive CD4+ T cells in nasal mucosa-associated lymphoid tissue following intranasal immunization with recombinant Streptococcus gordonii.Antigen binding to GM1 ganglioside results in delayed presentation: minimal effects of GM1 on presentation of antigens internalized via other pathways.
P2860

Intranasal immunization with cytotoxic T-lymphocyte epitope peptide and mucosal adjuvant cholera toxin: selective augmentation of peptide-presenting dendritic cells in nasal mucosa-associated lymphoid tissue

Item
http://www.wikidata.org/entity/Q33769366
description
1998 nî lūn-bûn
@nan
1998 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Intranasal immunization with c ...... osa-associated lymphoid tissue
@ast
Intranasal immunization with c ...... osa-associated lymphoid tissue
@en
type
label
Intranasal immunization with c ...... osa-associated lymphoid tissue
@ast
Intranasal immunization with c ...... osa-associated lymphoid tissue
@en
prefLabel
Intranasal immunization with c ...... osa-associated lymphoid tissue
@ast
Intranasal immunization with c ...... osa-associated lymphoid tissue
@en
P1433
P1476
P2093
P2860
P304
P31
P407
P433
P478
P577
P698
P921
P932
P1433
P1476
Intranasal immunization with c ...... osa-associated lymphoid tissue
@en
P2093
P2860
P304
P31
P407
P433
P478
P577
P698
P921
P932